Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Nuclear Medicine
Eckert & Ziegler gets GMP manufacturing authorization for Ac-225
By
AuntMinnieEurope.com staff writers
The firm is also planning Ac-225 production at its joint venture facility in China and further expansion in the U.S. and Germany.
October 28, 2026
AdvanCell reports data on Pb-212 PSMA therapy
By
AuntMinnie.com staff writers
Eighty percent of patients had a prostate-specific antigen (PSA) decline of at least 50%, according to the company.
October 26, 2026
EANM: Is ‘research fragmentation’ holding back nuclear medicine?
By
Will Morton
Well-designed studies require collaboration among nuclear medicine, medical oncology, urology, radiation oncology, and clinical trial support.
October 21, 2026
Telix posts revenue growth in Q3
By
AuntMinnie.com staff writers
For the period (end-September 30), Telix had group revenues of $245 million, up from $206 million in the same period last year.
October 21, 2026
EANM: Thomas Hope on what’s next in FAP-targeted theranostics
By
Will Morton
The innovations and work being done to optimize FAP agents will likely "spill over" to other targets.
October 19, 2026
Nuclidium, NorthStar sign Cu-67 supply and manufacturing deal
By
AuntMinnie.com staff writers
Cu-67 is the therapeutic half of Nuclidium’s theranostic platform, which pairs it with copper-61 (Cu-61) for diagnostic imaging.
October 19, 2026
Capitol Imaging Services acquires Impression Imaging
By
AuntMinnie.com staff writers
CIS said the deal is part of its expansion into molecular imaging and theranostics.
October 16, 2026
AtomVie, Jubilant Radiopharma enter distribution partnership
By
AuntMinnie.com staff writers
Jubilant will handle receipt, regulatory compliance, and distribution of AtomVie-manufactured radiopharmaceuticals.
October 15, 2026
Nusano, Primo Biotechnology ink isotope supply deal
By
AuntMinnie.com staff writers
The agreement will support Primo’s cancer therapy pipeline.
October 14, 2026
Lu-177 PNT2002 before SBRT extends disease control in prostate cancer
By
Will Morton
A group from the University of California, Los Angeles, updated an analysis of outcomes from the LUNAR trial by 10 months.
October 13, 2026
Jubilant to invest 94.5M CAD in manufacturing facility
By
AuntMinnie.com staff writers
The investment will double output of the firm's RubyFill rubidium-82 chloride cardiac PET agent.
October 9, 2026
Nuclidium images first patient in phase II trial of Cu-61 PSMA tracer
By
AuntMinnieEurope.com staff writers
The trial will enroll nearly three dozen patients with biopsy-confirmed metastatic prostate cancer at U.S. sites.
October 6, 2026
Page 1 of 446
Next Page